MARYLAND: MaxCyte Inc. (LON: MXCT) has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (SEC) relating to a proposed dual-listing and public offering of shares of common stock on the Nasdaq Stock Market. The number of securities to be offered and the price for the proposed Offering have…
All posts tagged Nasdaq Stock Market
Accustem Sciences Limited intends to list on Nasdaq Stock Market
NEW YORK: Tiziana Life Sciences announced that its former subsidiary Accustem Sciences Limited intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders. The board of directors of Accustem has resolved that the Nasdaq listing venue is more…